{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:09:38Z","timestamp":1790838578748,"version":"4.1.0"},"reference-count":113,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T00:00:00Z","timestamp":1739059200000},"content-version":"am","delay-in-days":374,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23ek0410106"],"award-info":[{"award-number":["JP23ek0410106"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005247","name":"The University of British Columbia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011775","name":"BC Children\u2019s Hospital Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012007","name":"Rockefeller University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012007","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001692","name":"Croucher Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002350","name":"St. Giles Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007421","name":"Li Ka Shing Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007421","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les H\u00e9patites Virales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000233","name":"Genome British Columbia","doi-asserted-by":"publisher","award":["SIP007"],"award-info":[{"award-number":["SIP007"]}],"id":[{"id":"10.13039\/501100000233","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10- IAHU-01"],"award-info":[{"award-number":["ANR-10- IAHU-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-21-CE15-0034"],"award-info":[{"award-number":["ANR-21-CE15-0034"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR001866"],"award-info":[{"award-number":["UL1TR001866"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008386","name":"Marmara \u00dcniversitesi","doi-asserted-by":"publisher","award":["ADT-2022-10661"],"award-info":[{"award-number":["ADT-2022-10661"]}],"id":[{"id":"10.13039\/501100008386","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008386","name":"Marmara \u00dcniversitesi","doi-asserted-by":"publisher","award":["R01AI126915"],"award-info":[{"award-number":["R01AI126915"]}],"id":[{"id":"10.13039\/501100008386","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008386","name":"Marmara \u00dcniversitesi","doi-asserted-by":"publisher","award":["R01AI128976"],"award-info":[{"award-number":["R01AI128976"]}],"id":[{"id":"10.13039\/501100008386","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017337","name":"Imagine Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012616","name":"Fondation Schlumberger pour l\u2019Education et la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012616","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000023","name":"Government of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000023","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017170","name":"Thailand Science Research and Innovation","doi-asserted-by":"publisher","award":["4708422"],"award-info":[{"award-number":["4708422"]}],"id":[{"id":"10.13039\/501100017170","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT 178054"],"award-info":[{"award-number":["PJT 178054"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021716","name":"Universit\u00e9 Paris Cit\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021716","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Immunology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.it.2023.12.003","type":"journal-article","created":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T03:04:12Z","timestamp":1705806252000},"page":"138-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Human germline gain-of-function in STAT6: from severe allergic disease to lymphoma and beyond"],"prefix":"10.1016","volume":"45","author":[{"given":"Mehul","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narissara","family":"Suratannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safa","family":"Baris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simran","family":"Samra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumiko","family":"Yanagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime S.","family":"Rosa Duque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Benamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate L.","family":"Del Bel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mana","family":"Momenilandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivien","family":"B\u00e9ziat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Laurent","family":"Casanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Martin","family":"van Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiro","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Kaname","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pantipa","family":"Chatchatee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talal A","family":"Chatila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Lung","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart E","family":"Turvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.it.2023.12.003_bb0005","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.jaci.2019.06.003","article-title":"Gain-of-function CEBPE mutation causes noncanonical autoinflammatory inflammasomopathy","volume":"144","author":"Goos","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0010","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s10875-022-01289-3","article-title":"Human inborn errors of immunity: 2022 update on the Classification from the International Union of Immunological Societies Expert Committee","volume":"42","author":"Tangye","year":"2022","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0015","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.ade7953","article-title":"A multimorphic mutation in IRF4 causes human autosomal dominant combined immunodeficiency","volume":"8","author":"IRF4 International Consortium","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0020","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jaci.2016.08.003","article-title":"Exome and genome sequencing for inborn errors of immunity","volume":"138","author":"Meyts","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0025","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1002\/eji.201444669","article-title":"Contribution of high-throughput DNA sequencing to the study of primary immunodeficiencies","volume":"44","author":"Picard","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0030","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.coi.2017.09.002","article-title":"Pathogenesis of infections in HIV-infected individuals: insights from primary immunodeficiencies","volume":"48","author":"Zhang","year":"2017","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0035","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1749-6632.2010.05834.x","article-title":"Life-threatening infectious diseases of childhood: single-gene inborn errors of immunity?","volume":"1214","author":"Alcais","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.it.2023.12.003_bb0040","doi-asserted-by":"crossref","first-page":"10430","DOI":"10.1073\/pnas.1903561116","article-title":"Homozygosity for TYK2 P1104A underlies tuberculosis in about 1% of patients in a cohort of European ancestry","volume":"116","author":"Kerner","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2023.12.003_bb0045","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aau8714","article-title":"Tuberculosis and impaired IL-23-dependent IFN-\u03b3 immunity in humans homozygous for a common TYK2 missense variant","volume":"3","author":"Boisson-Dupuis","year":"2018","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0050","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.jaci.2021.08.008","article-title":"Inborn errors of immunity manifesting as atopic disorders","volume":"148","author":"Vaseghi-Shanjani","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0055","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1084\/jem.20172306","article-title":"Primary atopic disorders","volume":"215","author":"Lyons","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2023.12.003_bb0060","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1146\/annurev-immunol-042718-041553","article-title":"Primary atopic disorders","volume":"38","author":"Milner","year":"2020","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0065","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.jaip.2022.04.001","article-title":"Atopy as immune dysregulation: offender genes and targets","volume":"10","author":"Vaseghi-Shanjani","year":"2022","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.it.2023.12.003_bb0070","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221755","article-title":"Human germline heterozygous gain-of-function STAT6 variants cause severe allergic disease","volume":"220","author":"Sharma","year":"2023","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2023.12.003_bb0075","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jaci.2022.09.028","article-title":"A germline STAT6 gain-of-function variant is associated with early-onset allergies","volume":"151","author":"Suratannon","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0080","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jaci.2023.01.023","article-title":"Severe allergic dysregulation due to a gain of function mutation in the transcription factor STAT6","volume":"152","author":"Baris","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0085","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.jaci.2022.12.802","article-title":"STAT6 gain-of-function variant exacerbates multiple allergic symptoms","volume":"151","author":"Takeuchi","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0090","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1007\/s10875-023-01530-7","article-title":"Autosomal dominant STAT6 gain of function causes severe atopy associated with lymphoma","volume":"43","author":"Minskaia","year":"2023","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0095","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0140-6736(66)90119-X","article-title":"Job's syndrome. Recurrent, \u2018cold\u2019, staphylococcal abscesses","volume":"1","author":"Davis","year":"1966","journal-title":"Lancet"},{"key":"10.1016\/j.it.2023.12.003_bb0100","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJM199903043400904","article-title":"Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder","volume":"340","author":"Grimbacher","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2023.12.003_bb0105","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20202592","article-title":"Human STAT3 variants underlie autosomal dominant hyper-IgE syndrome by negative dominance","volume":"218","author":"Asano","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2023.12.003_bb0110","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/ng1097","article-title":"Impaired response to interferon-alpha\/beta and lethal viral disease in human STAT1 deficiency","volume":"33","author":"Dupuis","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.it.2023.12.003_bb0115","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1172\/JCI37083","article-title":"A partial form of recessive STAT1 deficiency in humans","volume":"119","author":"Chapgier","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2023.12.003_bb0120","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1126\/science.1061154","article-title":"Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation","volume":"293","author":"Dupuis","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.it.2023.12.003_bb0125","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1084\/jem.20110958","article-title":"Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis","volume":"208","author":"Liu","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2023.12.003_bb0130","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMoa2202318","article-title":"Variant STAT4 and response to ruxolitinib in an autoinflammatory syndrome","volume":"388","author":"Baghdassarian","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2023.12.003_bb0135","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.jaci.2016.12.957","article-title":"JAK1 gain-of-function causes an autosomal dominant immune dysregulatory and hypereosinophilic syndrome","volume":"139","author":"Del Bel","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0140","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1084\/jem.20140280","article-title":"Human TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndrome","volume":"212","author":"Kreins","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2023.12.003_bb0145","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/377065a0","article-title":"Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)","volume":"377","author":"Macchi","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.it.2023.12.003_bb0150","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMoa1100102","article-title":"STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis","volume":"365","author":"van de Veerdonk","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2023.12.003_bb0155","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1073\/pnas.1220098110","article-title":"STAT2 deficiency and susceptibility to viral illness in humans","volume":"110","author":"Hambleton","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2023.12.003_bb0160","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1182\/blood-2014-11-610592","article-title":"STAT3: too much may be worse than not enough!","volume":"125","author":"Haddad","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.it.2023.12.003_bb0165","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1182\/blood-2014-09-602763","article-title":"Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations","volume":"125","author":"Milner","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.it.2023.12.003_bb0170","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.4049\/jimmunol.177.5.2770","article-title":"Cutting edge: Decreased accumulation and regulatory function of CD4+ CD25(high) T cells in human STAT5b deficiency","volume":"177","author":"Cohen","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0175","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3389\/fimmu.2012.00234","article-title":"The STAT5b pathway defect and autoimmunity","volume":"3","author":"Kanai","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0180","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1182\/blood-2016-09-737817","article-title":"Somatic STAT5b gain-of-function mutations in early onset nonclonal eosinophilia, urticaria, dermatitis, and diarrhea","volume":"129","author":"Ma","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.it.2023.12.003_bb0185","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20192319","article-title":"Homozygous STAT2 gain-of-function mutation by loss of USP18 activity in a patient with type I interferonopathy","volume":"217","author":"Gruber","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2023.12.003_bb0190","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jaci.2022.06.012","article-title":"Modulation of IL-4\/IL-13 cytokine signaling in the context of allergic disease","volume":"150","author":"Shankar","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0195","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.4049\/jimmunol.2100688","article-title":"STAT6-IP-dependent disruption of IL-33-mediated ILC2 expansion and type 2 innate immunity in the murine lung","volume":"209","author":"Moarbes","year":"2022","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0200","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.immuni.2014.04.013","article-title":"Basophil-derived interleukin-4 controls the function of natural helper cells, a member of ILC2s, in lung inflammation","volume":"40","author":"Motomura","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.it.2023.12.003_bb0205","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1002\/eji.201242433","article-title":"STAT6-dependent and -independent mechanisms in Th2 polarization","volume":"42","author":"Maier","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0210","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nri.2016.94","article-title":"T follicular helper cells in space-time","volume":"16","author":"Qi","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0215","doi-asserted-by":"crossref","first-page":"7997","DOI":"10.1038\/ncomms8997","article-title":"Batf is important for IL-4 expression in T follicular helper cells","volume":"6","author":"Sahoo","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.it.2023.12.003_bb0220","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1002\/eji.201344203","article-title":"B-cell-intrinsic STAT6 signaling controls germinal center formation","volume":"44","author":"Turqueti-Neves","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0225","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/intimm\/dxab080","article-title":"The role of IL-4 derived from follicular helper T (TFH) cells and type 2 helper T (TH2) cells","volume":"33","author":"Kubo","year":"2021","journal-title":"Int. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0230","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.jaci.2016.06.033","article-title":"Interleukins (from IL-1 to IL-38), interferons, transforming growth factor beta, and TNF-alpha: receptors, functions, and roles in diseases","volume":"138","author":"Akdis","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0235","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00403-019-01972-3","article-title":"The IL-4\/IL-13 axis in skin fibrosis and scarring: mechanistic concepts and therapeutic targets","volume":"312","author":"Nguyen","year":"2020","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.it.2023.12.003_bb0240","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nm734","article-title":"Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma","volume":"8","author":"Kuperman","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.it.2023.12.003_bb0245","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2249.2005.02875.x","article-title":"Interleukin-4 and interleukin-13 enhance CCL26 production in a human keratinocyte cell line, HaCaT cells","volume":"141","author":"Kagami","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0250","doi-asserted-by":"crossref","first-page":"6876","DOI":"10.4049\/jimmunol.163.12.6876","article-title":"Activation of eotaxin gene transcription by NF-kappa B and STAT6 in human airway epithelial cells","volume":"163","author":"Matsukura","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0255","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1111\/all.13935","article-title":"Human type 2 innate lymphoid cells disrupt skin keratinocyte tight junction barrier by IL-13","volume":"74","author":"Sugita","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.it.2023.12.003_bb0260","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jaci.2017.02.038","article-title":"Type 2 innate lymphoid cells disrupt bronchial epithelial barrier integrity by targeting tight junctions through IL-13 in asthmatic patients","volume":"141","author":"Sugita","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0265","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1165\/rcmb.2008-0162OC","article-title":"Interleukin-13 augments bronchial smooth muscle contractility with an up-regulation of RhoA protein","volume":"40","author":"Chiba","year":"2009","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.it.2023.12.003_bb0270","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1164\/ajrccm.160.4.9809065","article-title":"The failure of STAT6-deficient mice to develop airway eosinophilia and airway hyperresponsiveness is overcome by interleukin-5","volume":"160","author":"Tomkinson","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.it.2023.12.003_bb0275","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1084\/jem.187.9.1537","article-title":"Abrogation of bronchial eosinophilic inflammation and airway hyperreactivity in signal transducers and activators of transcription (STAT)6-deficient mice","volume":"187","author":"Akimoto","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2023.12.003_bb0280","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1084\/jem.187.6.939","article-title":"Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production","volume":"187","author":"Kuperman","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2023.12.003_bb0285","doi-asserted-by":"crossref","first-page":"17634","DOI":"10.1074\/jbc.273.28.17634","article-title":"Mutational analysis of the STAT6 SH2 domain","volume":"273","author":"Mikita","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.it.2023.12.003_bb0290","doi-asserted-by":"crossref","first-page":"14255","DOI":"10.1074\/jbc.C000129200","article-title":"A gain-of-function mutation in STAT6","volume":"275","author":"Daniel","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.it.2023.12.003_bb0295","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.4049\/jimmunol.170.7.3478","article-title":"Expression of a constitutively active Stat6 in vivo alters lymphocyte homeostasis with distinct effects in T and B cells","volume":"170","author":"Bruns","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0300","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.4049\/jimmunol.180.5.3551","article-title":"IL-4 is a critical determinant in the generation of allergic inflammation initiated by a constitutively active Stat6","volume":"180","author":"Sehra","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0305","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.jaci.2010.01.054","article-title":"In vivo regulation of the allergic response by the IL-4 receptor alpha chain immunoreceptor tyrosine-based inhibitory motif","volume":"125","author":"Tachdjian","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0310","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1038\/ncomms6593","article-title":"GWAS identifies four novel eosinophilic esophagitis loci","volume":"5","author":"Sleiman","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.it.2023.12.003_bb0315","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.cgh.2020.08.020","article-title":"STAT6 variants associate with relapse of eosinophilic esophagitis in patients receiving long-term proton pump inhibitor therapy","volume":"19","author":"Mougey","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.it.2023.12.003_bb0320","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1056\/NEJM199712113372403","article-title":"The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor","volume":"337","author":"Hershey","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2023.12.003_bb0325","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.jaci.2023.01.011","article-title":"The IL-4R\u03b1 Q576R polymorphism is associated with increased severity of atopic dermatitis and exaggerates allergic skin inflammation in mice","volume":"151","author":"Yang","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0330","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1084\/jem.20091480","article-title":"Pathogenicity of a disease-associated human IL-4 receptor allele in experimental asthma","volume":"206","author":"Tachdjian","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2023.12.003_bb0335","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1182\/blood-2014-06-582650","article-title":"Activating STAT6 mutations in follicular lymphoma","volume":"125","author":"Yildiz","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.it.2023.12.003_bb0340","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1182\/blood-2009-03-209759","article-title":"Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma","volume":"114","author":"Ritz","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.it.2023.12.003_bb0345","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41408-020-0335-0","article-title":"CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma","volume":"10","author":"Xian","year":"2020","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.it.2023.12.003_bb0350","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/bjh.15041","article-title":"The exomic landscape of t(14;18)-negative diffuse follicular lymphoma with 1p36 deletion","volume":"180","author":"Zamo","year":"2018","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.it.2023.12.003_bb0355","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1158\/1078-0432.CCR-15-2123","article-title":"Genetic landscapes of relapsed and refractory diffuse large B-cell lymphomas","volume":"22","author":"Morin","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.it.2023.12.003_bb0360","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ng.2856","article-title":"Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma","volume":"46","author":"Okosun","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.it.2023.12.003_bb0365","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: the catalogue of somatic mutations in cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.it.2023.12.003_bb0370","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.immuni.2020.07.006","article-title":"Complex autoinflammatory syndrome unveils fundamental principles of JAK1 kinase transcriptional and biochemical function","volume":"53","author":"Gruber","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.it.2023.12.003_bb0375","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/cea.14148","article-title":"A novel gain-of-function mutation in STAT5B is associated with treatment-resistant severe atopic dermatitis","volume":"52","author":"Kasap","year":"2022","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.it.2023.12.003_bb0380","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4049\/jimmunol.0903323","article-title":"Live cell imaging reveals continuous STAT6 nuclear trafficking","volume":"185","author":"Chen","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0385","article-title":"Autoinflammatory keratinization disease with hepatitis and autism reveals roles for JAK1 kinase hyperactivity in autoinflammation","volume":"12","author":"Takeichi","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0390","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S1074-7613(03)00292-9","article-title":"Stat5 activation plays a critical role in Th2 differentiation","volume":"19","author":"Zhu","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.it.2023.12.003_bb0395","doi-asserted-by":"crossref","first-page":"10026","DOI":"10.1074\/jbc.RA117.000567","article-title":"Small molecule targeting of the STAT5\/6 Src homology 2 (SH2) domains to inhibit allergic airway disease","volume":"293","author":"Knight","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.it.2023.12.003_bb0400","article-title":"STAT6 blockade abrogates aspergillus-induced eosinophilic chronic rhinosinusitis and asthma, a model of unified airway disease","volume":"13","author":"Sun","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0405","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1084\/jem.20190344","article-title":"Loss of the interleukin-6 receptor causes immunodeficiency, atopy, and abnormal inflammatory responses","volume":"216","author":"Spencer","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2023.12.003_bb0410","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jaci.2019.11.015","article-title":"Defining the biological responses of IL-6 by the study of a novel IL-6 receptor chain immunodeficiency","volume":"145","author":"Nahum","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0415","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1084\/jem.20161810","article-title":"A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis","volume":"214","author":"Schwerd","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2023.12.003_bb0420","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3324\/haematol.2018.194233","article-title":"Selective loss of function variants in IL6ST cause Hyper-IgE syndrome with distinct impairments of T-cell phenotype and function","volume":"104","author":"Shahin","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.it.2023.12.003_bb0425","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jaci.2021.02.044","article-title":"Functional and structural analysis of cytokine-selective IL6ST defects that cause recessive hyper-IgE syndrome","volume":"148","author":"Chen","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0430","article-title":"Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome","volume":"217","author":"B\u00e9ziat","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2023.12.003_bb0435","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aat4941","article-title":"ZNF341 controls STAT3 expression and thereby immunocompetence","volume":"3","author":"Frey-Jakobs","year":"2018","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0440","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006448","article-title":"TGFbeta receptor mutations impose a strong predisposition for human allergic disease","volume":"5","author":"Frischmeyer-Guerrerio","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.it.2023.12.003_bb0445","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1084\/jem.20161435","article-title":"ERBIN deficiency links STAT3 and TGF-beta pathway defects with atopy in humans","volume":"214","author":"Lyons","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2023.12.003_bb0450","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41423-023-01012-1","article-title":"IL-6 prevents Th2 cell polarization by promoting SOCS3-dependent suppression of IL-2 signaling","volume":"20","author":"Bachus","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0455","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/CIRCGENETICS.111.961235","article-title":"Frequent and widespread vascular abnormalities in human signal transducer and activator of transcription 3 deficiency","volume":"5","author":"Chandesris","year":"2012","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.it.2023.12.003_bb0460","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1056\/NEJMoa055695","article-title":"Aneurysm syndromes caused by mutations in the TGF-beta receptor","volume":"355","author":"Loeys","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2023.12.003_bb0465","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4049\/jimmunol.1401867","article-title":"Mechanisms of Jak\/STAT signaling in immunity and disease","volume":"194","author":"Villarino","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0470","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1126\/science.8085155","article-title":"An interleukin-4-induced transcription factor: IL-4 Stat","volume":"265","author":"Hou","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.it.2023.12.003_bb0475","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0161-5890(00)00088-2","article-title":"IL-4 induces serine phosphorylation of the STAT6 transactivation domain in B lymphocytes","volume":"37","author":"Wick","year":"2000","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0480","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1073\/pnas.92.7.3041","article-title":"Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity","volume":"92","author":"Seidel","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2023.12.003_bb0485","doi-asserted-by":"crossref","first-page":"45713","DOI":"10.1074\/jbc.M108132200","article-title":"Transcriptional activation by STAT6 requires the direct interaction with NCoA-1","volume":"276","author":"Litterst","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.it.2023.12.003_bb0490","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.4049\/jimmunol.171.7.3627","article-title":"Identification of novel IL-4\/Stat6-regulated genes in T lymphocytes","volume":"171","author":"Chen","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0495","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.bmc.2006.10.015","article-title":"Synthesis and evaluation of 2-[2-(4-hydroxyphenyl)-ethyl]aminopyrimidine-5-carboxamide derivatives as novel STAT6 inhibitors","volume":"15","author":"Nagashima","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.it.2023.12.003_bb0500","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1165\/rcmb.2008-0163OC","article-title":"A novel STAT6 inhibitor AS1517499 ameliorates antigen-induced bronchial hypercontractility in mice","volume":"41","author":"Chiba","year":"2009","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.it.2023.12.003_bb0505","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13223-022-00652-8","article-title":"The STAT6 inhibitor AS1517499 reduces the risk of asthma in mice with 2,4-dinitrochlorobenzene-induced atopic dermatitis by blocking the STAT6 signaling pathway","volume":"18","author":"Li","year":"2022","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0510","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1038\/sj.gt.3302341","article-title":"In vivo transfection of a cis element 'decoy' against signal transducers and activators of transcription 6 (STAT6)-binding site ameliorates IgE-mediated late-phase reaction in an atopic dermatitis mouse model","volume":"11","author":"Yokozeki","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.it.2023.12.003_bb0515","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1365-2133.2009.09070.x","article-title":"A therapeutic effect of STAT6 decoy oligodeoxynucleotide ointment in atopic dermatitis: a pilot study in adults","volume":"160","author":"Igawa","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.it.2023.12.003_bb0520","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1074\/jbc.M110.157768","article-title":"PARP-14 functions as a transcriptional switch for Stat6-dependent gene activation","volume":"286","author":"Mehrotra","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.it.2023.12.003_bb0525","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/s41375-022-01641-x","article-title":"PARP14 is a novel target in STAT6 mutant follicular lymphoma","volume":"36","author":"Mentz","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.it.2023.12.003_bb0530","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.jaci.2023.06.004","article-title":"Successful treatment of <em>JAK1-<\/em>associated inflammatory disease","volume":"152","author":"Fayand","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0535","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jaci.2021.08.009","article-title":"JAK inhibitors in the treatment of atopic dermatitis","volume":"148","author":"Chovatiya","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0540","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s12016-015-8506-7","article-title":"Hypereosinophilic syndrome","volume":"50","author":"Curtis","year":"2016","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.it.2023.12.003_bb0545","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41584-023-00958-w","article-title":"Evidence-based guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis","volume":"19","author":"Emmi","year":"2023","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.it.2023.12.003_bb0550","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.3109\/10428190309178786","article-title":"Eosinophilic variant of chronic myeloid leukemia with vascular complications","volume":"44","author":"Gotlib","year":"2003","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.it.2023.12.003_bb0555","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1182\/blood-2016-10-695973","article-title":"Myeloid neoplasms with eosinophilia","volume":"129","author":"Reiter","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.it.2023.12.003_bb0560","doi-asserted-by":"crossref","first-page":"13015","DOI":"10.1073\/pnas.1611228113","article-title":"Structural basis for DNA recognition by STAT6","volume":"113","author":"Li","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2023.12.003_bb0565","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.cell.2011.09.022","article-title":"Activation of STAT6 by STING is critical for antiviral innate immunity","volume":"147","author":"Chen","year":"2011","journal-title":"Cell"}],"container-title":["Trends in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490623002636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490623002636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T07:12:51Z","timestamp":1761462771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471490623002636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":113,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1471490623002636"],"URL":"https:\/\/doi.org\/10.1016\/j.it.2023.12.003","relation":{},"ISSN":["1471-4906"],"issn-type":[{"value":"1471-4906","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human germline gain-of-function in STAT6: from severe allergic disease to lymphoma and beyond","name":"articletitle","label":"Article Title"},{"value":"Trends in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.it.2023.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}